IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 194 filers reported holding IVERIC BIO INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,843,236 | +35.3% | 46,854 | -16.3% | 0.04% | +24.1% |
| Q1 2023 | $1,362,237 | +25.2% | 55,990 | +10.1% | 0.03% | +16.0% |
| Q4 2022 | $1,088,399 | -11.9% | 50,836 | -26.1% | 0.02% | -16.7% |
| Q3 2022 | $1,235,000 | +86.6% | 68,836 | +0.0% | 0.03% | +100.0% |
| Q2 2022 | $662,000 | -42.8% | 68,833 | 0.0% | 0.02% | -37.5% |
| Q1 2022 | $1,158,000 | +0.6% | 68,833 | 0.0% | 0.02% | +4.3% |
| Q4 2021 | $1,151,000 | +8.2% | 68,833 | +5.1% | 0.02% | 0.0% |
| Q3 2021 | $1,064,000 | +481.4% | 65,500 | +126.2% | 0.02% | +475.0% |
| Q2 2021 | $183,000 | – | 28,960 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |